Last reviewed · How we verify

NCT06035536

Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Completed NA Last updated 28 January 2026
What this trial tests

NA trial testing Symphony™ plus Off-loading in Diabetic Foot in 143 participants. Completed in 3 November 2025.

Timeline
8 June 2023
Primary endpoint
3 November 2025
3 November 2025

Quick facts

Lead sponsorAroa Biosurgery Limited
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment143
Start date8 June 2023
Primary completion3 November 2025
Estimated completion3 November 2025
Sites11 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Aroa Biosurgery Limited

Who can join

18 and older, any sex, with Diabetic Foot or Diabetic Foot Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will evaluate the safety and performance of Symphony™ versus Standard of Care (SOC) in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetic Foot

Currently open trials in the same condition.

Other Aroa Biosurgery Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06035536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing